Pyrophosphate (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the Pyrophosphate drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
NON-PROPRIETARY NAME: | Pyrophosphate |
SUBSTANCE NAME: | SODIUM PYROPHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-05-23 |
END MARKETING DATE: | 0000-00-00 |
Pyrophosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | Pyrophosphate from AnazaoHealth Corporation |
LABELER NAME: | AnazaoHealth Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 27.6(mg/1) |
START MARKETING DATE: | 2012-05-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51808-218_e247d821-b132-4a87-a71a-8bc13c71fcfc |
PRODUCT NDC: | 51808-218 |
APPLICATION NUMBER: | |
Other SODIUM PYROPHOSPHATE Pharmaceutical Manufacturers / Labelers: